IQity

2 days ago

IQity has officially completed its first U.S. 🇺🇸 clinical case using the IQ-Flow handheld ECP device. This is an important milestone in expanding access to next-generation glaucoma treatment.

We’re grateful to Dr. Farrell “Toby” Tyson for his partnership, clinical insight, and early leadership in bringing this technology into practice.

#IQity #IQFlow #GlaucomaCare #Ophthalmology #ECP #MedicalInnovation #SurgeryTech

IQity

3 days ago

Endoscopic Cyclophotocoagulation (ECP) remains one of the most effective yet underutilized options in glaucoma treatment. By directly targeting the ciliary processes, ECP reduces aqueous production at the source, thereby providing a dependable, minimally invasive method for lowering IOP. Despite these outcomes, ECP adoption has lagged behind other MIGS options. 

Our goal is to help surgeons adopt ECP with greater confidence, consistency, and efficiency, enabling the procedure to reach its full potential as a core part of modern glaucoma care. 

Swipe to see our what, why, and how. 

#ECP #glaucoma #IQ Flow

Read the document here

IQity

Nov 27, 2025

𝐇𝐚𝐩𝐩𝐲 𝐓𝐡𝐚𝐧𝐤𝐬𝐠𝐢𝐯𝐢𝐧𝐠 𝐟𝐫𝐨𝐦 𝐚𝐥𝐥 𝐨𝐟 𝐮𝐬 𝐚𝐭 𝐈𝐐𝐢𝐭𝐲!

Today, we’re grateful for the global ophthalmology community – surgeons, researchers, nurses, technicians, and partners – who work every day to protect and restore sight.

At IQity, our mission is to support that work:
Using technology to deliver superior visual outcomes, reduce human error, and ease the growing pressure on healthcare systems.

Thank you for the trust, the collaboration, and the shared dedication to better eye care.

Wishing you and your families a wonderful and meaningful Thanksgiving. 🧡🍂
Your IQity Team

#Thanksgiving #Gratitude #Ophthalmology

IQity

Nov 26, 2025

We’re building the future of ophthalmic technology and 𝐲𝐨𝐮 𝐜𝐚𝐧 𝐟𝐨𝐥𝐥𝐨𝐰 𝐞𝐯𝐞𝐫𝐲 𝐬𝐭𝐞𝐩 𝐨𝐟 𝐢𝐭.

The IQity website is giving you a full view of our portfolio across diagnostics, surgery, and chronic disease management.

You can now:
🔹 Explore the entire IQity technology ecosystem
🔹 See current launch timelines. E.g. for IQ Flow, IQ Meter, and IQ SurgiView
🔹 Sign up for product-specific updates and be the first to know when new data, milestones, or clinical insights are released

As we prepare multiple innovations for launch, this is the easiest way to stay connected to what’s coming and how it will help reduce time burden, improve outcomes, and lower costs across the ophthalmic workflow.

👉 Visit https://iqity.tech/ and register for the updates that matter to you.
We’re just getting started.

IQity

Nov 25, 2025

𝐅𝐢𝐫𝐬𝐭 𝐔𝐒 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐂𝐚𝐬𝐞𝐬 𝐰𝐢𝐭𝐡 𝐈𝐐 𝐅𝐥𝐨𝐰

Recently, Dr. Farrell “Toby” Tyson became the first surgeon in the United States to perform clinical cases with the IQ Flow, triple-action handheld endoscopic cyclophotocoagulation (ECP) device.

IQ Flow stands for more control, more access and less friction in glaucoma care for surgeons and patients. Dr. Tyson’s early cases are a proof point of what we’ve believed since day one:
🔹 ECP doesn’t need to be bulky to be effective
🔹 Innovation should simplify, not complicate, the OR

Thank you, Dr. Tyson, for your trust, your skill, and your readiness to lead.
Onward!

#Ophthalmology #Glaucoma #ECP

IQity

Nov 20, 2025

AI in ophthalmology isn’t just about accuracy it’s about 𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐜𝐲.


A new review in Applied Sciences MDPI highlights a reality every ophthalmologist already feels: The demand for eye care is exploding, while the available clinical workforce is not.

The paper points to where AI can make the biggest difference:
– Automating routine diagnostics
– Reducing variability in clinical decision-making
– Supporting surgical planning and postoperative care
– Streamlining workflows across imaging modalities
– Expanding access through teleophthalmology and remote diagnostics

This is exactly where we believe the next decade of innovation must focus.
At IQity, our technologies are built to give surgeons more efficiency, more clarity, and more impact .

𝐎𝐮𝐫 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐮𝐬𝐞 𝐀𝐈 𝐭𝐨 𝐡𝐞𝐥𝐩 𝐬𝐮𝐫𝐠𝐞𝐨𝐧𝐬 𝐝𝐞𝐥𝐢𝐯𝐞𝐫 𝐰𝐨𝐫𝐥𝐝-𝐜𝐥𝐚𝐬𝐬 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬, 𝐫𝐞𝐠𝐚𝐫𝐝𝐥𝐞𝐬𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐜𝐨𝐧𝐬𝐭𝐫𝐚𝐢𝐧𝐭𝐬 𝐚𝐫𝐨𝐮𝐧𝐝 𝐭𝐡𝐞𝐦.

👉 Learn more about our platform at https://iqity.tech/, and follow along as we move toward ASCRS 2026.

Read the document here

IQity

Nov 18, 2025

“𝐀𝐦𝐚𝐳𝐢𝐧𝐠”

That was the first reaction from Rajen Desai, MD (The Witlin Center, NJ) after getting his hands on IQ-Flow, our handheld, AI-enabled endoscopic cyclophotocoagulation (ECP) device.

In his words, “Endoscopic, AI-enabled ECP… I’m planning to use it really, really soon.”

IQ-Flow is designed to reshape what surgeons expect from inflow-based glaucoma treatment technologies and we’re incredibly grateful for the enthusiasm and honest feedback from leading surgeons like Dr. Desai.

It fuels our mission to bring 𝐠𝐫𝐞𝐚𝐭𝐞𝐫 𝐢𝐦𝐩𝐚𝐜𝐭, 𝐥𝐨𝐰𝐞𝐫 𝐜𝐨𝐬𝐭, 𝐚𝐧𝐝 𝐛𝐞𝐭𝐭𝐞𝐫 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬 𝐭𝐨 𝐨𝐩𝐡𝐭𝐡𝐚𝐥𝐦𝐢𝐜 𝐜𝐚𝐫𝐞.

👉 Explore more IQity technologies at https://iqity.tech/ and sign up for updates as we move toward ASCRS 2026.

#IQity #ECP #Glaucoma

IQity

Nov 14, 2025

The new IQ-Flow brings a 𝐡𝐚𝐧𝐝𝐡𝐞𝐥𝐝, 𝐞𝐚𝐬𝐲 𝐭𝐨 𝐮𝐬𝐞 𝐄𝐂𝐏 𝐭𝐨 𝐠𝐥𝐚𝐮𝐜𝐨𝐦𝐚 𝐜𝐚𝐫𝐞. AI-titrated laser power will enable even more surgeons to use ECP as part of their glaucoma treatment paragidm.

Its endoscopic imaging is one of a kind.

And yes… there is a reason it is called “triple-action” – we’re just getting started 🤫

👉 Learn more at https://iqity.tech/ and subscribe for updates on upcoming IQFlow innovations.
#ECP #GlaucomaSurgery #Innovation

IQity

Nov 11, 2025

𝐅𝐢𝐫𝐬𝐭 𝐈𝐦𝐩𝐫𝐞𝐬𝐬𝐢𝐨𝐧𝐬 𝐌𝐚𝐭𝐭𝐞𝐫 
We had the privilege of hosting Dr. Farrell “Toby” Tyson, ophthalmic surgeon and board member of IQity, for his first hands-on demo of the IQ-Meter, IQ-Flow (ECP), and IQ-SurgiView systems.

In this short video, Dr. Tyson shares his initial impressions from the intuitive design to the seamless integration of data and visualization that define the IQity experience.

At IQity, we believe that the future of ophthalmic surgery lies in connected intelligence, where every device communicates, every detail matters, and surgeons are empowered with real-time insights that elevate outcomes and reduce cost.

#Ophthalmology #Innovation #IQity
Tyson Eye

IQity

Nov 6, 2025

The feature set of our 𝐈𝐐-𝐌𝐞𝐭𝐞𝐫 is nothing short of spectacular – truly an all-in-one solution designed to support every step of the ophthalmic workflow, pre- and postoperatively.

And the best part? There’s even more innovation on the way 🤫

👉 Visit https://iqity.tech/ to learn more and subscribe for updates on the IQ-Meter launch.

#Diagnostics #TrulyAllinOne #IQity